Annual CFO
-$71.74 M
-$12.01 M-20.10%
31 December 2023
Summary:
IO Biotech annual cash flow from operations is currently -$71.74 million, with the most recent change of -$12.01 million (-20.10%) on 31 December 2023. During the last 3 years, it has fallen by -$61.78 million (-620.54%). IOBT annual CFO is now -706.85% below its all-time high of -$8.89 million, reached on 31 December 2019.IOBT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$20.81 M
-$3.83 M-22.53%
30 September 2024
Summary:
IO Biotech quarterly cash flow from operations is currently -$20.81 million, with the most recent change of -$3.83 million (-22.53%) on 30 September 2024. Over the past year, it has dropped by -$4.82 million (-30.13%). IOBT quarterly CFO is now -434.64% below its all-time high of -$3.89 million, reached on 31 March 2021.IOBT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$85.52 M
-$4.82 M-5.97%
30 September 2024
Summary:
IO Biotech TTM cash flow from operations is currently -$85.52 million, with the most recent change of -$4.82 million (-5.97%) on 30 September 2024. Over the past year, it has dropped by -$24.05 million (-39.12%). IOBT TTM CFO is now -2097.25% below its all-time high of -$3.89 million, reached on 31 March 2021.IOBT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IOBT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.1% | -30.1% | -39.1% |
| 3 y3 years | -620.5% | -154.7% | -299.5% |
| 5 y5 years | - | - | - |
IOBT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -620.5% | at low | -154.7% | +16.5% | -299.5% | at low |
| 5 y | 5 years | -706.9% | at low | -434.6% | +16.5% | -2097.3% | at low |
| alltime | all time | -706.9% | at low | -434.6% | +16.5% | -2097.3% | at low |
IO Biotech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.81 M(+22.5%) | -$85.52 M(+6.0%) |
| June 2024 | - | -$16.98 M(-31.9%) | -$80.70 M(-1.6%) |
| Mar 2024 | - | -$24.93 M(+9.4%) | -$81.98 M(+14.3%) |
| Dec 2023 | -$71.74 M(+20.1%) | -$22.80 M(+42.6%) | -$71.74 M(+16.7%) |
| Sept 2023 | - | -$15.99 M(-12.4%) | -$61.47 M(+4.5%) |
| June 2023 | - | -$18.26 M(+24.3%) | -$58.83 M(+9.8%) |
| Mar 2023 | - | -$14.69 M(+17.3%) | -$53.58 M(-10.3%) |
| Dec 2022 | -$59.73 M | -$12.53 M(-6.2%) | -$59.73 M(-10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$13.35 M(+2.6%) | -$66.44 M(+8.5%) |
| June 2022 | - | -$13.01 M(-37.6%) | -$61.27 M(+6.4%) |
| Mar 2022 | - | -$20.84 M(+8.3%) | -$57.60 M(+41.7%) |
| Dec 2021 | -$40.65 M(+308.3%) | -$19.24 M(+135.5%) | -$40.65 M(+89.9%) |
| Sept 2021 | - | -$8.17 M(-12.5%) | -$21.41 M(+61.7%) |
| June 2021 | - | -$9.34 M(+140.1%) | -$13.23 M(+240.1%) |
| Mar 2021 | - | -$3.89 M | -$3.89 M |
| Dec 2020 | -$9.96 M(+12.0%) | - | - |
| Dec 2019 | -$8.89 M | - | - |
FAQ
- What is IO Biotech annual cash flow from operations?
- What is the all time high annual CFO for IO Biotech?
- What is IO Biotech annual CFO year-on-year change?
- What is IO Biotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for IO Biotech?
- What is IO Biotech quarterly CFO year-on-year change?
- What is IO Biotech TTM cash flow from operations?
- What is the all time high TTM CFO for IO Biotech?
- What is IO Biotech TTM CFO year-on-year change?
What is IO Biotech annual cash flow from operations?
The current annual CFO of IOBT is -$71.74 M
What is the all time high annual CFO for IO Biotech?
IO Biotech all-time high annual cash flow from operations is -$8.89 M
What is IO Biotech annual CFO year-on-year change?
Over the past year, IOBT annual cash flow from operations has changed by -$12.01 M (-20.10%)
What is IO Biotech quarterly cash flow from operations?
The current quarterly CFO of IOBT is -$20.81 M
What is the all time high quarterly CFO for IO Biotech?
IO Biotech all-time high quarterly cash flow from operations is -$3.89 M
What is IO Biotech quarterly CFO year-on-year change?
Over the past year, IOBT quarterly cash flow from operations has changed by -$4.82 M (-30.13%)
What is IO Biotech TTM cash flow from operations?
The current TTM CFO of IOBT is -$85.52 M
What is the all time high TTM CFO for IO Biotech?
IO Biotech all-time high TTM cash flow from operations is -$3.89 M
What is IO Biotech TTM CFO year-on-year change?
Over the past year, IOBT TTM cash flow from operations has changed by -$24.05 M (-39.12%)